{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:13:55Z","timestamp":1747152835551,"version":"3.40.5"},"publisher-location":"Cham","reference-count":88,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031658266"},{"type":"electronic","value":"9783031658273"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/16833_2022_95","type":"book-chapter","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T11:09:56Z","timestamp":1671102596000},"page":"415-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nutrient Transporters: New Molecular Targets for Triple Negative Breast Cancer in Type 2 Diabetics"],"prefix":"10.1007","author":[{"given":"Cl\u00e1udia","family":"Silva","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-3416","authenticated-orcid":false,"given":"F\u00e1tima","family":"Martel","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"95_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/cancers11010062","volume":"11","author":"S Ando","year":"2019","unstructured":"Ando S, Gelsomino L, Panza S, Giordano C, Bonofiglio D, Barone I, Catalano S (2019) Obesity, leptin and breast cancer: epidemiological evidence and proposed mechanisms. Cancers (Basel) 11:62. https:\/\/doi.org\/10.3390\/cancers11010062","journal-title":"Cancers (Basel)"},{"key":"95_CR2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MCO.0b013e32833a5577","volume":"13","author":"A Annibaldi","year":"2010","unstructured":"Annibaldi A, Widmann C (2010) Glucose metabolism in cancer cells. Curr Opin Clin Nutr Metab Care 13:466\u2013470. https:\/\/doi.org\/10.1097\/MCO.0b013e32833a5577","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"95_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/cancers12010154","volume":"12","author":"AM Barbosa","year":"2020","unstructured":"Barbosa AM, Martel F (2020) Targeting glucose transporters for breast cancer therapy: the effect of natural and synthetic compounds. Cancers (Basel) 12:154. https:\/\/doi.org\/10.3390\/cancers12010154","journal-title":"Cancers (Basel)"},{"key":"95_CR5","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/bjc.2012.414","volume":"107","author":"P Boyle","year":"2012","unstructured":"Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, Fairley LL, Boniol M, Zheng T, Zhang Y, Pasterk M, Smans M, Curado MP, Mullie P, Gandini S, Bota M, Bolli GB, Rosenstock J, Autier P (2012) Diabetes and breast cancer risk: a meta-analysis. Br J Cancer 107:1608\u20131617. https:\/\/doi.org\/10.1038\/bjc.2012.414","journal-title":"Br J Cancer"},{"key":"95_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170084","volume":"12","author":"HK Bronsveld","year":"2017","unstructured":"Bronsveld HK, Jensen V, Vahl P, De Bruin ML, Cornelissen S, Sanders J, Auvinen A, Haukka J, Andersen M, Vestergaard P, Schmidt MK (2017) Diabetes and breast cancer subtypes. PLoS One 12:e0170084. https:\/\/doi.org\/10.1371\/journal.pone.0170084","journal-title":"PLoS One"},{"key":"95_CR7","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1186\/1471-2407-14-941","volume":"14","author":"MD Cao","year":"2014","unstructured":"Cao MD, Lamichhane S, Lundgren S, Bofin A, Fjosne H, Giskeodegard GF, Bathen TF (2014) Metabolic characterization of triple negative breast cancer. BMC Cancer 14:941. https:\/\/doi.org\/10.1186\/1471-2407-14-941","journal-title":"BMC Cancer"},{"key":"95_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/cancers12051119","volume":"12","author":"S Cassim","year":"2020","unstructured":"Cassim S, Vucetic M, Zdralevic M, Pouyssegur J (2020) Warburg and beyond: the power of mitochondrial metabolism to collaborate or replace fermentative glycolysis in cancer. Cancers (Basel) 12:1119. https:\/\/doi.org\/10.3390\/cancers12051119","journal-title":"Cancers (Basel)"},{"key":"95_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/ijms19030907","volume":"19","author":"YJ Cha","year":"2018","unstructured":"Cha YJ, Kim ES, Koo JS (2018) Amino acid transporters and glutamine metabolism in breast cancer. Int J Mol Sci 19:907. https:\/\/doi.org\/10.3390\/ijms19030907","journal-title":"Int J Mol Sci"},{"key":"95_CR10","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1158\/1055-9965.EPI-19-0291","volume":"28","author":"H Chen","year":"2019","unstructured":"Chen H, Cook LS, Tang MC, Hill DA, Wiggins CL, Li CI (2019) Relationship between diabetes and diabetes medications and risk of different molecular subtypes of breast cancer. Cancer Epidemiol Biomark Prev 28:1802\u20131808. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0291","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"95_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4062\/biomolther.2017.178","volume":"26","author":"YK Choi","year":"2018","unstructured":"Choi YK, Park KG (2018) Targeting glutamine metabolism for cancer treatment. Biomol Ther (Seoul) 26:19\u201328. https:\/\/doi.org\/10.4062\/biomolther.2017.178","journal-title":"Biomol Ther (Seoul)"},{"key":"95_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000339513","volume":"80","author":"J Choi","year":"2013","unstructured":"Choi J, Jung WH, Koo JS (2013) Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry. Pathobiology 80:41\u201352. https:\/\/doi.org\/10.1159\/000339513","journal-title":"Pathobiology"},{"key":"95_CR13","first-page":"587","volume":"20","author":"JG Cory","year":"2006","unstructured":"Cory JG, Cory AH (2006) Critical roles of glutamine as nitrogen donors in purine and pyrimidine nucleotide synthesis: asparaginase treatment in childhood acute lymphoblastic leukemia. In Vivo 20:587\u2013589","journal-title":"In Vivo"},{"key":"95_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.coph.2016.11.004","volume":"31","author":"E Crespi","year":"2016","unstructured":"Crespi E, Bottai G, Santarpia L (2016) Role of inflammation in obesity-related breast cancer. Curr Opin Pharmacol 31:114\u2013122. https:\/\/doi.org\/10.1016\/j.coph.2016.11.004","journal-title":"Curr Opin Pharmacol"},{"key":"95_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2:e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200","journal-title":"Sci Adv"},{"key":"95_CR16","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 104:19345\u201319350. https:\/\/doi.org\/10.1073\/pnas.0709747104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"95_CR17","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1038\/s41598-017-06378-7","volume":"7","author":"T Dong","year":"2017","unstructured":"Dong T, Liu Z, Xuan Q, Wang Z, Ma W, Zhang Q (2017) Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis. Sci Rep 7:6069. https:\/\/doi.org\/10.1038\/s41598-017-06378-7","journal-title":"Sci Rep"},{"key":"95_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.molcel.2012.05.043","volume":"47","author":"RV Duran","year":"2012","unstructured":"Duran RV, Oppliger W, Robitaille AM, Heiserich L, Skendaj R, Gottlieb E, Hall MN (2012) Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 47:349\u2013358. https:\/\/doi.org\/10.1016\/j.molcel.2012.05.043","journal-title":"Mol Cell"},{"key":"95_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/his.13334","volume":"72","author":"R El Ansari","year":"2018","unstructured":"El Ansari R, McIntyre A, Craze ML, Ellis IO, Rakha EA, Green AR (2018) Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations. Histopathology 72:183\u2013190. https:\/\/doi.org\/10.1111\/his.13334","journal-title":"Histopathology"},{"key":"95_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","volume":"5","author":"Y Feng","year":"2018","unstructured":"Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, Liu B, Lei Y, Du S, Vuppalapati A, Luu HH, Haydon RC, He TC, Ren G (2018) Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 5:77\u2013106. https:\/\/doi.org\/10.1016\/j.gendis.2018.05.001","journal-title":"Genes Dis"},{"key":"95_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/183928","volume":"2015","author":"P Ferroni","year":"2015","unstructured":"Ferroni P, Riondino S, Buonomo O, Palmirotta R, Guadagni F, Roselli M (2015) Type 2 diabetes and breast cancer: the interplay between impaired glucose metabolism and oxidant stress. Oxidative Med Cell Longev 2015:183928. https:\/\/doi.org\/10.1155\/2015\/183928","journal-title":"Oxidative Med Cell Longev"},{"key":"95_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s13402-016-0282-8","volume":"39","author":"LA Flores-Lopez","year":"2016","unstructured":"Flores-Lopez LA, Martinez-Hernandez MG, Viedma-Rodriguez R, Diaz-Flores M, Baiza-Gutman LA (2016) High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells. Cell Oncol (Dordr) 39:365\u2013378. https:\/\/doi.org\/10.1007\/s13402-016-0282-8","journal-title":"Cell Oncol (Dordr)"},{"key":"95_CR23","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","volume":"13","author":"MI Gross","year":"2014","unstructured":"Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J, Mackinnon AL, Parlati F, Rodriguez ML, Shwonek PJ, Sjogren EB, Stanton TF, Wang T, Yang J, Zhao F, Bennett MK (2014) Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther 13:890\u2013901. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0870","journal-title":"Mol Cancer Ther"},{"key":"95_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1530\/JME-13-0062","volume":"51","author":"C Gupta","year":"2013","unstructured":"Gupta C, Tikoo K (2013) High glucose and insulin differentially modulates proliferation in MCF-7 and MDA-MB-231 cells. J Mol Endocrinol 51:119\u2013129. https:\/\/doi.org\/10.1530\/JME-13-0062","journal-title":"J Mol Endocrinol"},{"key":"95_CR25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"95_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F (2019) Breast cancer. Nat Rev Dis Primers 5:66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2","journal-title":"Nat Rev Dis Primers"},{"key":"95_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1530\/ERC-12-0242","volume":"19","author":"PJ Hardefeldt","year":"2012","unstructured":"Hardefeldt PJ, Edirimanne S, Eslick GD (2012) Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cancer 19:793\u2013803. https:\/\/doi.org\/10.1530\/ERC-12-0242","journal-title":"Endocr Relat Cancer"},{"key":"95_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay N (2016) Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer 16:635\u2013649. https:\/\/doi.org\/10.1038\/nrc.2016.77","journal-title":"Nat Rev Cancer"},{"key":"95_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2147\/BCTT.S135665","volume":"9","author":"Y Hou","year":"2017","unstructured":"Hou Y, Zhou M, Xie J, Chao P, Feng Q, Wu J (2017) High glucose levels promote the proliferation of breast cancer cells through GTPases. Breast Cancer (Dove Med Press) 9:429\u2013436. https:\/\/doi.org\/10.2147\/BCTT.S135665","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"95_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.breast.2016.08.014","volume":"30","author":"X Huang","year":"2016","unstructured":"Huang X, Li X, Xie X, Ye F, Chen B, Song C, Tang H, Xie X (2016) High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer. Breast 30:39\u201346. https:\/\/doi.org\/10.1016\/j.breast.2016.08.014","journal-title":"Breast"},{"key":"95_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1593\/tlo.11256","volume":"4","author":"YR Hussein","year":"2011","unstructured":"Hussein YR, Bandyopadhyay S, Semaan A, Ahmed Q, Albashiti B, Jazaerly T, Nahleh Z, Ali-Fehmi R (2011) Glut-1 expression correlates with basal-like breast cancer. Transl Oncol 4:321\u2013327. https:\/\/doi.org\/10.1593\/tlo.11256","journal-title":"Transl Oncol"},{"key":"95_CR32","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.31557\/APJCP.2018.19.11.3175","volume":"19","author":"I Isnaini","year":"2018","unstructured":"Isnaini I, Permatasari N, Mintaroem K, Prihardina B, Widodo MA (2018) Oxidants-antioxidants profile in the breast cancer cell line MCF-7. Asian Pac J Cancer Prev 19:3175\u20133178. https:\/\/doi.org\/10.31557\/APJCP.2018.19.11.3175","journal-title":"Asian Pac J Cancer Prev"},{"key":"95_CR33","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/emboj.2012.45","volume":"31","author":"S Jiang","year":"2012","unstructured":"Jiang S, Zhang LF, Zhang HW, Hu S, Lu MH, Liang S, Li B, Li Y, Li D, Wang ED, Liu MF (2012) A novel miR-155\/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J 31:1985\u20131998. https:\/\/doi.org\/10.1038\/emboj.2012.45","journal-title":"EMBO J"},{"key":"95_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.redox.2017.04.018","volume":"12","author":"B Kalyanaraman","year":"2017","unstructured":"Kalyanaraman B (2017) Teaching the basics of cancer metabolism: developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism. Redox Biol 12:833\u2013842. https:\/\/doi.org\/10.1016\/j.redox.2017.04.018","journal-title":"Redox Biol"},{"key":"95_CR35","first-page":"279","volume":"11","author":"YM Kanaan","year":"2014","unstructured":"Kanaan YM, Sampey BP, Beyene D, Esnakula AK, Naab TJ, Ricks-Santi LJ, Dasi S, Day A, Blackman KW, Frederick W, Copeland RL Sr, Gabrielson E, Dewitty RL Jr (2014) Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease. Cancer Genomics Proteomics 11:279\u2013294","journal-title":"Cancer Genomics Proteomics"},{"key":"95_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jdsr.2017.08.003","volume":"54","author":"Y Kato","year":"2018","unstructured":"Kato Y, Maeda T, Suzuki A, Baba Y (2018) Cancer metabolism: new insights into classic characteristics. Jpn Dent Sci Rev 54:8\u201321. https:\/\/doi.org\/10.1016\/j.jdsr.2017.08.003","journal-title":"Jpn Dent Sci Rev"},{"key":"95_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/ERC-12-0398","volume":"20","author":"S Kim","year":"2013","unstructured":"Kim S, Kim DH, Jung WH, Koo JS (2013a) Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. Endocr Relat Cancer 20:339\u2013348. https:\/\/doi.org\/10.1530\/ERC-12-0398","journal-title":"Endocr Relat Cancer"},{"key":"95_CR38","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s13277-013-0707-1","volume":"34","author":"S Kim","year":"2013","unstructured":"Kim S, Kim DH, Jung WH, Koo JS (2013b) Metabolic phenotypes in triple-negative breast cancer. Tumour Biol 34:1699\u20131712. https:\/\/doi.org\/10.1007\/s13277-013-0707-1","journal-title":"Tumour Biol"},{"key":"95_CR39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00428-017-2083-5","volume":"470","author":"JY Kim","year":"2017","unstructured":"Kim JY, Heo SH, Choi SK, Song IH, Park IA, Kim YA, Park HS, Park SY, Bang WS, Gong G, Lee HJ (2017) Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes. Virchows Arch 470:381\u2013389. https:\/\/doi.org\/10.1007\/s00428-017-2083-5","journal-title":"Virchows Arch"},{"key":"95_CR40","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.12659\/MSM.915368","volume":"25","author":"Y Kong","year":"2019","unstructured":"Kong Y, Dong Q, Ji H, Sang M, Ding Y, Zhao M, Yang H, Geng C (2019) The effect of the leptin and leptin receptor expression on the efficacy of neoadjuvant chemotherapy in breast cancer. Med Sci Monit 25:3005\u20133013. https:\/\/doi.org\/10.12659\/MSM.915368","journal-title":"Med Sci Monit"},{"key":"95_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002229","volume":"7","author":"HN Kung","year":"2011","unstructured":"Kung HN, Marks JR, Chi JT (2011) Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genet 7:e1002229. https:\/\/doi.org\/10.1371\/journal.pgen.1002229","journal-title":"PLoS Genet"},{"key":"95_CR42","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ijc.22717","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856\u2013862. https:\/\/doi.org\/10.1002\/ijc.22717","journal-title":"Int J Cancer"},{"key":"95_CR43","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1073\/pnas.0511253103","volume":"103","author":"CH Lee","year":"2006","unstructured":"Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, Evans RM (2006) PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci U S A 103:3444\u20133449. https:\/\/doi.org\/10.1073\/pnas.0511253103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"95_CR44","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.14694\/EdBook_AM.2015.35.e31","volume":"35","author":"BD Lehmann","year":"2015","unstructured":"Lehmann BD, Pietenpol JA, Tan AR (2015) Triple-negative breast cancer: molecular subtypes and new targets for therapy. Am Soc Clin Oncol Educ Book 35:e31\u2013e39. https:\/\/doi.org\/10.14694\/EdBook_AM.2015.35.e31","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"95_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejphar.2018.07.007","volume":"837","author":"Y Liu","year":"2018","unstructured":"Liu Y, Zhao T, Li Z, Wang L, Yuan S, Sun L (2018) The role of ASCT2 in cancer: a review. Eur J Pharmacol 837:81\u201387. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.007","journal-title":"Eur J Pharmacol"},{"key":"95_CR46","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G (2021) Breast cancer. Lancet 397:1750\u20131769. https:\/\/doi.org\/10.1016\/S0140-6736(20)32381-3","journal-title":"Lancet"},{"key":"95_CR47","doi-asserted-by":"publisher","first-page":"628","DOI":"10.14348\/molcells.2019.0038","volume":"42","author":"C Ma","year":"2019","unstructured":"Ma C, Zu X, Liu K, Bode AM, Dong Z, Liu Z, Kim DJ (2019) Knockdown of pyruvate kinase M inhibits cell growth and migration by reducing NF-kB activity in triple-negative breast cancer cells. Mol Cells 42:628\u2013636. https:\/\/doi.org\/10.14348\/molcells.2019.0038","journal-title":"Mol Cells"},{"key":"95_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436\u2013444. https:\/\/doi.org\/10.1038\/nature07205","journal-title":"Nature"},{"key":"95_CR49","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1530\/JOE-18-0037","volume":"237","author":"SD Martin","year":"2018","unstructured":"Martin SD, McGee SL (2018) Metabolic reprogramming in type 2 diabetes and the development of breast cancer. J Endocrinol 237:R35\u2013R46. https:\/\/doi.org\/10.1530\/JOE-18-0037","journal-title":"J Endocrinol"},{"key":"95_CR50","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10602","volume":"481","author":"CM Metallo","year":"2011","unstructured":"Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, Jewell CM, Johnson ZR, Irvine DJ, Guarente L, Kelleher JK, Vander Heiden MG, Iliopoulos O, Stephanopoulos G (2011) Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481:380\u2013384. https:\/\/doi.org\/10.1038\/nature10602","journal-title":"Nature"},{"key":"95_CR51","doi-asserted-by":"publisher","first-page":"19177","DOI":"10.18632\/oncotarget.3910","volume":"6","author":"F Morais-Santos","year":"2015","unstructured":"Morais-Santos F, Granja S, Miranda-Goncalves V, Moreira AH, Queiros S, Vilaca JL, Schmitt FC, Longatto-Filho A, Paredes J, Baltazar F, Pinheiro C (2015) Targeting lactate transport suppresses in vivo breast tumour growth. Oncotarget 6:19177\u201319189. https:\/\/doi.org\/10.18632\/oncotarget.3910","journal-title":"Oncotarget"},{"key":"95_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.trsl.2017.07.004","volume":"189","author":"MP Ogrodzinski","year":"2017","unstructured":"Ogrodzinski MP, Bernard JJ, Lunt SY (2017) Deciphering metabolic rewiring in breast cancer subtypes. Transl Res 189:105\u2013122. https:\/\/doi.org\/10.1016\/j.trsl.2017.07.004","journal-title":"Transl Res"},{"key":"95_CR53","doi-asserted-by":"publisher","first-page":"132","DOI":"10.5483\/bmbrep.2017.50.3.189","volume":"50","author":"S Oh","year":"2017","unstructured":"Oh S, Kim H, Nam K, Shin I (2017) Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells. BMB Rep 50:132\u2013137. https:\/\/doi.org\/10.5483\/bmbrep.2017.50.3.189","journal-title":"BMB Rep"},{"key":"95_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/BF03348015","volume":"20","author":"V Papa","year":"1997","unstructured":"Papa V, Milazzo G, Goldfine ID, Waldman FM, Vigneri R (1997) Sporadic amplification of the insulin receptor gene in human breast cancer. J Endocrinol Investig 20:531\u2013536. https:\/\/doi.org\/10.1007\/BF03348015","journal-title":"J Endocrinol Investig"},{"key":"95_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"},{"key":"95_CR56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3892\/ol.2021.12630","volume":"21","author":"J Peng","year":"2021","unstructured":"Peng J, Cui Y, Xu S, Wu X, Huang Y, Zhou W, Wang S, Fu Z, Xie H (2021) Altered glycolysis results in drug-resistant in clinical tumor therapy. Oncol Lett 21:369. https:\/\/doi.org\/10.3892\/ol.2021.12630","journal-title":"Oncol Lett"},{"key":"95_CR57","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.14670\/HH-26.1279","volume":"26","author":"C Pinheiro","year":"2011","unstructured":"Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F, Baltazar F (2011) GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histol Histopathol 26:1279\u20131286. https:\/\/doi.org\/10.14670\/HH-26.1279","journal-title":"Histol Histopathol"},{"key":"95_CR58","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1593\/neo.04430","volume":"7","author":"IF Robey","year":"2005","unstructured":"Robey IF, Lien AD, Welsh SJ, Baggett BK, Gillies RJ (2005) Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 7:324\u2013330. https:\/\/doi.org\/10.1593\/neo.04430","journal-title":"Neoplasia"},{"key":"95_CR59","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ctrv.2018.08.004","volume":"70","author":"SM Samuel","year":"2018","unstructured":"Samuel SM, Varghese E, Varghese S, Busselberg D (2018) Challenges and perspectives in the treatment of diabetes associated breast cancer. Cancer Treat Rev 70:98\u2013111. https:\/\/doi.org\/10.1016\/j.ctrv.2018.08.004","journal-title":"Cancer Treat Rev"},{"key":"95_CR60","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3389\/fonc.2019.00596","volume":"9","author":"F Sanchez-Jimenez","year":"2019","unstructured":"Sanchez-Jimenez F, Perez-Perez A, de la Cruz-Merino L, Sanchez-Margalet V (2019) Obesity and breast cancer: role of leptin. Front Oncol 9:596. https:\/\/doi.org\/10.3389\/fonc.2019.00596","journal-title":"Front Oncol"},{"key":"95_CR61","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3389\/fonc.2019.00480","volume":"9","author":"FL Sarmiento-Salinas","year":"2019","unstructured":"Sarmiento-Salinas FL, Delgado-Magallon A, Montes-Alvarado JB, Ramirez-Ramirez D, Flores-Alonso JC, Cortes-Hernandez P, Reyes-Leyva J, Herrera-Camacho I, Anaya-Ruiz M, Pelayo R, Millan-Perez-Pena L, Maycotte P (2019) Breast cancer subtypes present a differential production of reactive oxygen species (ROS) and susceptibility to antioxidant treatment. Front Oncol 9:480. https:\/\/doi.org\/10.3389\/fonc.2019.00480","journal-title":"Front Oncol"},{"key":"95_CR62","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/cells10051056","volume":"10","author":"C Schiliro","year":"2021","unstructured":"Schiliro C, Firestein BL (2021) Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cell 10:1056. https:\/\/doi.org\/10.3390\/cells10051056","journal-title":"Cell"},{"key":"95_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.728759","volume":"9","author":"E Shin","year":"2021","unstructured":"Shin E, Koo JS (2021) Glucose metabolism and glucose transporters in breast cancer. Front Cell Dev Biol 9:728759. https:\/\/doi.org\/10.3389\/fcell.2021.728759","journal-title":"Front Cell Dev Biol"},{"key":"95_CR64","doi-asserted-by":"publisher","first-page":"18699","DOI":"10.1038\/s41598-019-55296-3","volume":"9","author":"R Shiratori","year":"2019","unstructured":"Shiratori R, Furuichi K, Yamaguchi M, Miyazaki N, Aoki H, Chibana H, Ito K, Aoki S (2019) Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner. Sci Rep 9:18699. https:\/\/doi.org\/10.1038\/s41598-019-55296-3","journal-title":"Sci Rep"},{"key":"95_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173980","volume":"898","author":"C Silva","year":"2021","unstructured":"Silva C, Andrade N, Guimaraes JT, Patricio E, Martel F (2021a) The in vitro effect of the diabetes-associated markers insulin, leptin and oxidative stress on cellular characteristics promoting breast cancer progression is GLUT1-dependent. Eur J Pharmacol 898:173980. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173980","journal-title":"Eur J Pharmacol"},{"key":"95_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120054","volume":"286","author":"C Silva","year":"2021","unstructured":"Silva C, Andrade N, Rodrigues I, Ferreira AC, Soares ML, Martel F (2021b) The pro-proliferative effect of interferon-gamma in breast cancer cell lines is dependent on stimulation of ASCT2-mediated glutamine cellular uptake. Life Sci 286:120054. https:\/\/doi.org\/10.1016\/j.lfs.2021.120054","journal-title":"Life Sci"},{"key":"95_CR67","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cbf.3681","volume":"40","author":"C Silva","year":"2022","unstructured":"Silva C, Andrade N, Guimaraes JT, Cardoso E, Meireles C, Pinto V, Paiva J, Martel F (2022) The pro-proliferative effect of insulin in human breast epithelial DMBA-transformed and non-transformed cell lines is PI3K-, mTOR- and GLUT1-dependent. Cell Biochem 40:127\u2013137 Funct. https:\/\/doi.org\/10.1002\/cbf.3681","journal-title":"Cell Biochem"},{"key":"95_CR68","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fonc.2020.00428","volume":"10","author":"X Sun","year":"2020","unstructured":"Sun X, Wang M, Wang M, Yu X, Guo J, Sun T, Li X, Yao L, Dong H, Xu Y (2020) Metabolic reprogramming in triple-negative breast cancer. Front Oncol 10:428. https:\/\/doi.org\/10.3389\/fonc.2020.00428","journal-title":"Front Oncol"},{"key":"95_CR69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"95_CR70","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/molecules26082179","volume":"26","author":"WH Talib","year":"2021","unstructured":"Talib WH, Mahmod AI, Abuarab SF, Hasen E, Munaim AA, Haif SK, Ayyash AM, Khater S, Al-Yasari IH, Kury LTA (2021) Diabetes and cancer: metabolic association, therapeutic challenges, and the role of natural products. Molecules 26:2179. https:\/\/doi.org\/10.3390\/molecules26082179","journal-title":"Molecules"},{"key":"95_CR71","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00280-020-04218-6","volume":"87","author":"E Teixeira","year":"2021","unstructured":"Teixeira E, Silva C, Martel F (2021) The role of the glutamine transporter ASCT2 in antineoplastic therapy. Cancer Chemother Pharmacol 87:447\u2013464. https:\/\/doi.org\/10.1007\/s00280-020-04218-6","journal-title":"Cancer Chemother Pharmacol"},{"key":"95_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","volume":"27","author":"JYS Tsang","year":"2020","unstructured":"Tsang JYS, Tse GM (2020) Molecular classification of breast cancer. Adv Anat Pathol 27:27\u201335. https:\/\/doi.org\/10.1097\/PAP.0000000000000232","journal-title":"Adv Anat Pathol"},{"key":"95_CR73","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1038\/onc.2015.381","volume":"35","author":"M van Geldermalsen","year":"2016","unstructured":"van Geldermalsen M, Wang Q, Nagarajah R, Marshall AD, Thoeng A, Gao D, Ritchie W, Feng Y, Bailey CG, Deng N, Harvey K, Beith JM, Selinger CI, O\u2019Toole SA, Rasko JE, Holst J (2016) ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene 35:3201\u20133208. https:\/\/doi.org\/10.1038\/onc.2015.381","journal-title":"Oncogene"},{"key":"95_CR74","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrd3504","volume":"10","author":"MG Vander Heiden","year":"2011","unstructured":"Vander Heiden MG (2011) Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10:671\u2013684. https:\/\/doi.org\/10.1038\/nrd3504","journal-title":"Nat Rev Drug Discov"},{"key":"95_CR75","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/ncb1807","volume":"10","author":"AE Vaughn","year":"2008","unstructured":"Vaughn AE, Deshmukh M (2008) Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol 10:1477\u20131483. https:\/\/doi.org\/10.1038\/ncb1807","journal-title":"Nat Cell Biol"},{"key":"95_CR76","doi-asserted-by":"publisher","first-page":"21629","DOI":"10.1038\/srep21629","volume":"6","author":"L Venturelli","year":"2016","unstructured":"Venturelli L, Nappini S, Bulfoni M, Gianfranceschi G, Dal Zilio S, Coceano G, Del Ben F, Turetta M, Scoles G, Vaccari L, Cesselli D, Cojoc D (2016) Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells. Sci Rep 6:21629. https:\/\/doi.org\/10.1038\/srep21629","journal-title":"Sci Rep"},{"key":"95_CR77","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.bbrc.2014.10.109","volume":"454","author":"F Wang","year":"2014","unstructured":"Wang F, Yang Y (2014) Inhibition of PKM2 sensitizes triple-negative breast cancer cells to doxorubicin. Biochem Biophys Res Commun 454:465\u2013470. https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.109","journal-title":"Biochem Biophys Res Commun"},{"key":"95_CR78","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519\u2013530. https:\/\/doi.org\/10.1085\/jgp.8.6.519","journal-title":"J Gen Physiol"},{"key":"95_CR79","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","volume":"11","author":"Q Wu","year":"2020","unstructured":"Wu Q, Ba-Alawi W, Deblois G, Cruickshank J, Duan S, Lima-Fernandes E, Haight J, Tonekaboni SAM, Fortier AM, Kuasne H, McKee TD, Mahmoud H, Kushida M, Cameron S, Dogan-Artun N, Chen W, Nie Y, Zhang LX, Vellanki RN, Zhou S, Prinos P, Wouters BG, Dirks PB, Done SJ, Park M, Cescon DW, Haibe-Kains B, Lupien M, Arrowsmith CH (2020) GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. Nat Commun 11:4205. https:\/\/doi.org\/10.1038\/s41467-020-18020-8","journal-title":"Nat Commun"},{"key":"95_CR80","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0005-2736(01)00384-4","volume":"1514","author":"O Yanagida","year":"2001","unstructured":"Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, Cha SH, Matsuo H, Fukushima J, Fukasawa Y, Tani Y, Taketani Y, Uchino H, Kim JY, Inatomi J, Okayasu I, Miyamoto K, Takeda E, Goya T, Endou H (2001) Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514:291\u2013302. https:\/\/doi.org\/10.1016\/s0005-2736(01)00384-4","journal-title":"Biochim Biophys Acta"},{"key":"95_CR81","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang L, Venneti S, Nagrath D (2017) Glutaminolysis: a Hallmark of cancer metabolism. Annu Rev Biomed Eng 19:163\u2013194. https:\/\/doi.org\/10.1146\/annurev-bioeng-071516-044546","journal-title":"Annu Rev Biomed Eng"},{"key":"95_CR82","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3760\/cma.j.issn.0253-9624.2018.03.007","volume":"52","author":"F Yi","year":"2018","unstructured":"Yi F, Diao S, Yuan XL, Li JY (2018) Association of plasma leptin levels and soluble leptin receptor with breast cancer. Zhonghua Yu Fang Yi Xue Za Zhi 52:253\u2013259. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-9624.2018.03.007","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"95_CR83","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM (2020) Glutamine reliance in cell metabolism. Exp Mol Med 52:1496\u20131516. https:\/\/doi.org\/10.1038\/s12276-020-00504-8","journal-title":"Exp Mol Med"},{"key":"95_CR84","first-page":"2895","volume":"15","author":"M Younes","year":"1995","unstructured":"Younes M, Brown RW, Mody DR, Fernandez L, Laucirica R (1995) GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res 15:2895\u20132898","journal-title":"Anticancer Res"},{"key":"95_CR85","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3760\/cma.j.issn.0253-9624.2017.06.015","volume":"51","author":"XL Yuan","year":"2017","unstructured":"Yuan XL, Xu ZP, Liu CR, Yan LP, Tao P, Xiong P, Li Q, Zhou M, Li H, Zhao M, Li JY (2017) Study of the association between polymorphism of persistent obesity, human leptin gene\/leptin receptor gene and molecular subtypes of breast cancer. Zhonghua Yu Fang Yi Xue Za Zhi 51:533\u2013538. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-9624.2017.06.015","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"95_CR86","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1471-4159.1990.tb08831.x","volume":"55","author":"M Yudkoff","year":"1990","unstructured":"Yudkoff M, Pleasure D, Cregar L, Lin ZP, Nissim I, Stern J, Nissim I (1990) Glutathione turnover in cultured astrocytes: studies with [15N]glutamate. J Neurochem 55:137\u2013145. https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb08831.x","journal-title":"J Neurochem"},{"key":"95_CR87","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/carcin\/bgx035","volume":"38","author":"W Zhang","year":"2017","unstructured":"Zhang W, Xu Y, Xu Q, Shi H, Shi J, Hou Y (2017) PPARdelta promotes tumor progression via activation of Glut1 and SLC1-A5 transcription. Carcinogenesis 38:748\u2013755. https:\/\/doi.org\/10.1093\/carcin\/bgx035","journal-title":"Carcinogenesis"},{"key":"95_CR88","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ol.2012.928","volume":"4","author":"J Zheng","year":"2012","unstructured":"Zheng J (2012) Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (Review). Oncol Lett 4:1151\u20131157. https:\/\/doi.org\/10.3892\/ol.2012.928","journal-title":"Oncol Lett"},{"key":"95_CR89","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88\u201398. https:\/\/doi.org\/10.1038\/nrendo.2017.151","journal-title":"Nat Rev Endocrinol"}],"container-title":["Interdisciplinary Cancer Research","Breast Cancer Treatment: An Interdisciplinary Approach"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/16833_2022_95","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T14:54:03Z","timestamp":1724770443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/16833_2022_95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031658266","9783031658273"],"references-count":88,"URL":"https:\/\/doi.org\/10.1007\/16833_2022_95","relation":{},"ISSN":["2731-4561","2731-457X"],"issn-type":[{"type":"print","value":"2731-4561"},{"type":"electronic","value":"2731-457X"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"16 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}